Last reviewed · How we verify

NCT07298109

Diaphragmatic Release for Low Back Pain

Recruiting now NA Last updated 23 December 2025
What this trial tests

NA trial testing Manual diaphragm release in Low Back Pain in 42 participants. Currently enrolling.

Timeline
11 December 2025
Primary endpoint
15 October 2026
15 December 2026

Quick facts

Lead sponsorKarabuk University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment42
Start date11 December 2025
Primary completion15 October 2026
Estimated completion15 December 2026
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Karabuk University

Who can join

Adults 18 to 65, any sex, with Low Back Pain or Diaphragm; Relaxation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Low back pain is one of the most common musculoskeletal disorders, significantly affecting the quality of life of individuals. In non-specific low back pain, a lack of stabilization in the core region negatively impacts the performance of activities. The diaphragm forms the framework of the core region, and its dysfunction can contribute to both respiratory problems and low back pain. This study will investigate the effects of diaphragm relaxation, added to spinal stabilization exercises, on pain, disability, quality of life, central sensitization, and trunk muscle endurance.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Low Back Pain

Currently open trials in the same condition.

Other Karabuk University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07298109.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing